Viewing Study NCT03036150


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2026-02-03 @ 1:20 PM
Study NCT ID: NCT03036150
Status: COMPLETED
Last Update Posted: 2021-07-07
First Post: 2017-01-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Kidney Disease (CKD) View
None Cardiovascular Events (CV) View
None Phase III outcome trial View